Felicitex Therapeutics is a company developing treatments for dormant cancers. It offers therapeutics that target both dormant and proliferating cancers and improve long-term outcomes of treatments for the most therapy-resistant liquid and solid tumors such as hematopoietic, ovarian, pancreatic, colorectal, osteosarcoma, glioblastoma, and lung.